March is Myeloma Awareness Month. Multiple myeloma is a blood cancer that most often occurs in people older than 45. It’s the second-most common blood cancer and the most common blood cancer in Black ...

PHOENIX--(BUSINESS WIRE)-- DNA methylation — a modification of DNA linked to gene regulation — is altered with increasing severity in a blood cancer called multiple myeloma, according to a study by ...

The early findings of a Mayo Clinic study, published this month in the journal Leukemia, indicate the drug thalidomide can stop or slow the progression of multiple myeloma in patients newly diagnosed ...

A Mayo Clinic study indicates patients who are newly diagnosed with multiple myeloma, a cancer of the bone marrow, may have a new and better-tolerated option to intravenous chemotherapy treatment.

ROCHESTER, Minn. -- A Mayo Clinic study is the first to show that for some patients with early stage multiple myeloma, the drug thalidomide may effectively delay the need for chemotherapy or more ...

The news reporters obtained a quote from the research from Mayo Clinic, "High costs of life-saving drugs are detrimental to both the personal finances of the individual patient, as well as society ...

SCOTTSDALE, Ariz.--(BUSINESS WIRE)-- Research on the same protein that was a primary mediator of the birth defects caused by thalidomide now holds hope in the battle against multiple myeloma, say Mayo ...

ROCHESTER, Minn. — A new Mayo Clinic study published in the New England Journal of Medicine has uncovered that an off-the-shelf, dual-antibody therapy can generate deep and durable responses in ...

In a proof of principle clinical trial, Mayo Clinic researchers have demonstrated that virotherapy — destroying cancer with a virus that infects and kills cancer cells but spares normal tissues — can ...

Time-based measurements were extracted using a scheduling/pharmacy software program that tracked patient movement through appointments for patients initiating DARA in Mayo Clinic infusion centers from ...

Multiple myeloma is a relatively uncommon form of blood cancer that affects less than 1% of the U.S. population, according the American Cancer Society. March is Myeloma Awareness Month. People younger ...